Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,285 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002904 | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors | completed | Phase 1 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00002916 | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 |
| clinicaltrials |
| NCT00002972 | Paclitaxel in Treating Patients With Lung Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00003026 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 3 | 966 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT00003028 | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003061 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 2, 2012 | clinicaltrials |
| NCT00003062 | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00003148 | Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia | completed | Phase 2 | 86 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 2, 2012 | clinicaltrials |
| NCT00003152 | Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | terminated | Phase 3 | 469 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00780598 | Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML(OPAL) | completed | Phase 2 | 76 | Chroma TherapeuticsINDUSTRY | 3 | Jun 28, 2012 | clinicaltrials |
| NCT00435409 | A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer | completed | Phase 3 | 442 | PfizerINDUSTRY | 18 | Jun 26, 2012 | clinicaltrials |
| NCT01096641 | An Explorative Study on Physiological and Neurophysiological Determinants of Fatigue in Cancer Survivors | unknown | N/A | 57 | Radboud University Medical CenterOTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00141531 | Phase II Trial of EOquin in High-risk Superficial Bladder Cancer | completed | Phase 2 | 53 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib(ENEST) | completed | Phase 3 | 248 | Novartis PharmaceuticalsINDUSTRY | 13 | Jun 12, 2012 | clinicaltrials |
| NCT00048659 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 10 | Jun 7, 2012 | clinicaltrials |
| NCT00257478 | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | — | Astellas Pharma IncINDUSTRY | 3 | Jun 7, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study(TRAIN) | completed | Phase 2 | 111 | The Netherlands Cancer InstituteOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT01262183 | Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus(PANORAMIC) | terminated | Phase 2 | 4 | Radboud University Medical CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00911027 | SonoVue Guided Prostate Biopsy | terminated | Phase 3 | 282 | Bracco Diagnostics, IncINDUSTRY | 7 | Apr 25, 2012 | clinicaltrials |
| NCT00863850 | Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy | completed | Phase 1 | 6 | CephalonINDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT00420927 | Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis(OPTIMA) | completed | Phase 4 | 1,032 | AbbottINDUSTRY | 21 | Apr 18, 2012 | clinicaltrials |
| NCT00035100 | EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | completed | Phase 2 | 54 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 16, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00774319 | TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer(Condor) | unknown | Phase 2 | 70 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00982631 | A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer | unknown | Phase 1 | 30 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT01246817 | Temsirolimus-RCC-imaging | unknown | Phase 2 | 51 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT01437865 | Gadofosveset for Axillary Staging in Breast Cancer Patients | completed | N/A | 10 | Maastricht University Medical CenterOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT01338090 | 89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors(NETPET) | completed | — | 14 | University Medical Center GroningenOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00991978 | VEGF Early Imaging for Breast Cancer | completed | Early Phase 1 | 23 | University Medical Center GroningenOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00991614 | EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms | completed | — | 110 | Cook Group IncorporatedINDUSTRY | 5 | Mar 29, 2012 | clinicaltrials |
| NCT00706095 | Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System | completed | Phase 1 | 18 | Eisai Inc.INDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study(ARTS) | completed | Phase 2 | 294 | GlaxoSmithKlineINDUSTRY | 9 | Mar 21, 2012 | clinicaltrials |
| NCT00860860 | Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer(PRIT2008) | completed | Phase 1 | 20 | Radboud University Medical CenterOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT01526759 | Fiber Longer Term Study on Energy Intake(FLiTS) | completed | N/A | 35 | Wageningen UniversityOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00908908 | A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 6 | Eisai Inc.INDUSTRY | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00928798 | Topical Rapamycin for Fibrofolliculomas | completed | Phase 3 | 19 | Maastricht University Medical CenterOTHER | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00003279 | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer(SILVA) | completed | Phase 3 | 500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Mar 6, 2012 | clinicaltrials |
| NCT00003304 | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | completed | Phase 2 | 29 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 450 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | terminated | Phase 2 | 43 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Mar 6, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00737555 | A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours | completed | Phase 1 | 23 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00288821 | Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology | completed | — | 84 | UMC UtrechtOTHER | 1 | Feb 9, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials